$SNYR

Synergy CHC Corp. (SNYR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 1.03 Bankruptcy or Receivership. On September 4, 2026, Synergy CHC Corp. (the “Company”) filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Columbia (t

Synergy CHC Corp. (SNYR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001562733 0001562733 2026-06-29 2026-06-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor

This article announces an SEC filing (Form ARS) by Synergy CHC Corp. (SNYR) on April 30, 2026, at 4:18 PM. The filing is categorized with low impact and neutral sentiment, and a PDF document is available for viewing. The article also provides a brief overview of SNYR's stock, market cap ranking, recent news, and other SEC filings.

Synergy CHC Corp. (SNYR) is seeking stockholder approval for several key proposals at its 2026 virtual annual meeting on June 29, 2026. These include electing directors, ratifying auditors, significantly increasing its 2024 Equity Incentive Plan share reserve to 150,000,000 common shares and allowing repricing of awards, approving the full issuance of shares under a Lender Warrant for Nasdaq compliance, and authorizing a reverse stock split at a ratio of up to 1-for-200. These proposals aim to increase capital flexibility, maintain Nasdaq listing, and align executive and stockholder interests, despite potential dilution concerns and a reported net loss of $(12.3) million in 2025.

Synergy CHC has announced a delay in filing its annual Form 10-K for the fiscal year ended December 31, 2025, due to ongoing work on its financial statements. The company expects to submit the report within the 15-day extension period and does not anticipate significant changes in operating results. TipRanks' AI Analyst, Spark, rates SNYR as Neutral due to balance sheet stress and negative cash generation, despite improved profitability and a low P/E valuation.

Synergy CHC Corp. (NASDAQ: SNYR) has announced a revised date for its fourth quarter and full-year 2025 financial results, moving the release to Wednesday, April 1, 2026, before market open. A conference call with CEO Jack Ross and CFO Jaime Fickett will follow at 9:00 a.m. ET. The company will discuss its financial performance and provide updates to investors during the call.

Synergy CHC Corp. (NASDAQ:SNYR) will be featured on Bloomberg Television's "New to The Street" on Saturday, November 1st, at 6:30 PM ET. The segment will highlight the company's growth, innovative marketing, and expanding retail presence for its Focus Factor® brand and other wellness products. This appearance aims to provide viewers with insights into Synergy's role in the health and performance supplement market and its future expansion strategies.

The show airs as sponsored programming with TV commercials by Synergy CHC, Sustainable Green Team, Laser Pharmaceuticals, and PetVivo. New to The Street, one of the nation's leading multi-platform financial media brands, announces the broadcast of Show Number 702, airing today on Bloomberg ...

Synergy CHC Corp. (SNYR) delivered earnings and revenue surprises of 0.00% and -26.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

WESTBROOK, Maine, Oct. 20, 2025 ( GLOBE NEWSWIRE ) -- Synergy CHC Corp. ( NASDAQ:SNYR ) , a leading consumer health and wellness company, today announced a strategic distribution partnership with Atlantic Importing Company, one of Southern New England's top multi-category distributors.